Halozyme Therapeutics, Inc.
USD77.58
+0.40 (+0.52%)
CEO
Helen I. Torley
IPO Date
2004-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$77.46
Prev. Close
$77.18
Day Low
$77.26
Day High
$78.25
52W Low
$51.78
52W High
$82.22
Market Cap
$9.20B
Volume
0.22M
| 13.7 |
| 31 Dec 2023 | FY | 76.8% | 34.0% | 336.0% | 16.2% | 17.89 | 6.64 | 17.3 |
| 31 Dec 2022 | FY | 78.9% | 30.6% | 119.0% | 11.0% | 8.87 | 5.65 | 38.5 |
| 31 Dec 2021 | FY | 81.6% | 90.8% | 204.5% | 36.5% | 4.45 | 7.91 | 14.0 |
| 31 Dec 2020 | FY | 83.8% | 48.2% | 85.5% | 22.3% | 2.63 | 1.32 | 45.1 |
| 31 Dec 2019 | FY | 76.8% | -36.9% | -78.7% | -12.8% | 4.39 | 6.35 | -35.4 |
| 31 Dec 2018 | FY | 93.3% | -52.9% | -32.3% | -18.2% | 0.51 | 2.86 | -26.1 |
| 31 Dec 2017 | FY | 90.2% | 19.9% | 30.2% | 12.1% | 0.97 | 3.89 | 43.9 |
| 31 Dec 2016 | FY | 77.4% | -70.2% | 317.2% | -39.4% | -6.67 | 4.70 | -12.2 |
| -14.0 |
| 30 Sept 2025 | Q3 | 79.4% | 49.5% | 34.8% | 7.9% | 3.00 | 1.59 | 12.3 |
| 30 Jun 2025 | Q2 | 80.3% | 50.7% | 49.6% | 8.0% | 4.54 | 8.36 | 9.6 |
| 31 Mar 2025 | Q1 | 75.0% | 44.6% | 24.5% | 5.4% | 3.13 | 8.39 | 16.6 |
| 31 Dec 2024 | Q4 | 85.9% | 46.0% | 37.7% | 6.6% | 4.14 | 7.80 | 11.0 |
| 30 Sept 2024 | Q3 | 83.0% | 47.2% | 30.3% | 6.5% | 3.32 | 10.36 | 13.2 |
| 30 Jun 2024 | Q2 | 75.2% | 40.3% | 32.2% | 4.7% | 5.19 | 7.41 | 17.7 |
| 31 Mar 2024 | Q1 | 76.5% | 39.2% | 43.2% | 4.2% | 8.44 | 6.64 | 17.1 |
| 31 Dec 2023 | Q4 | 77.3% | 37.1% | 101.9% | 4.9% | 17.89 | 6.64 | 14.0 |